Valneva and Pfizer Report Six-Month Antibody Persistence Data in Children and Adults for Lyme Disease Vaccine Candidate

Antibody levels remained above baseline six months after completion of a three-dose (Month 0-2-6) or a two-dose (Month 0-6) vaccination schedule Higher antibody levels were observed in the three-dose vaccination schedule versus the two-dose...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials